All Stories

  1. Visual Performance of Two Daily Disposable Multifocal Contact Lenses in Presbyopic Soft Lens Wearers
  2. An In Vitro Evaluation of the Effect and Protection of Artificial Tear Formulations on Human Corneal Epithelial Cells in Normal and Dry Eye Disease States
  3. A Clinical Evaluation of Lifitegrast Ophthalmic Solution 5% in Symptomatic Contact Lens Wearers
  4. Performance of Delefilcon A Daily Disposable Contact Lenses in a Group of Digital Device Users
  5. Clinical practice patterns in the management of dry eye disease: A TFOS international survey 2023-24
  6. The Impact of Comfort Eluting Agents and Replacement Frequency on Enhancing Contact Lens Performance
  7. Biodegradable 3D-Printed Conjunctival Inserts for the Treatment of Dry Eyes
  8. 3D-Printed Contact Lenses to Release Polyvinyl Alcohol as a Therapeutic Agent for the Treatment of Dry Eyes
  9. Investigation of Delefilcon A Contact Lenses for Symptomatic Daily Disposable Contact Lens Wearers with Dry Eye Disease: A Prospective Comparative Study
  10. Evaluation of Lag of Accommodation with Full-Field Diffusion Optics Technology™ (DOT) Contrast Management Spectacle Lenses in Emmetropic Children
  11. Fabrication and Characterization of an Enzyme-Triggered, Therapeutic-Releasing Hydrogel Bandage Contact Lens Material
  12. Evaluating the Performance of Verofilcon A Daily Disposable Contact Lenses in a Group of Heavy Digital Device Users
  13. TFOS Lifestyle: Impact of contact lenses on the ocular surface
  14. In vitro–in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink model
  15. Short-term tolerability of commercial eyelid cleansers: A randomised crossover study
  16. Antiviral Activity of Contemporary Contact Lens Care Solutions against Two Human Seasonal Coronavirus Strains
  17. The impact of contact lenses on meibomian gland morphology
  18. Clinical practice patterns in the management of dry eye disease: A TFOS international survey
  19. Bibliometric analysis of the meibomian gland literature
  20. CLEAR - Contact lens technologies of the future
  21. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial
  22. Bibliometric analysis of the literature relating to scleral contact lenses
  23. Activity of Deposited Lysozyme on Contemporary Soft Contact Lenses Exposed to Differing Lens Care Systems
  24. The Impact of Incubation Conditions on In Vitro Phosphatidylcholine Deposition on Contact Lens Materials
  25. Global optometrist top 200 research ranking
  26. In vitro analysis of the interaction of tear film inflammatory markers with contemporary contact lens materials
  27. The impact of patient behaviour and care system compliance on reusable soft contact lens complications
  28. Bibliometric analysis of the refractive error field
  29. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
  30. In vitro Evaluation of the Location of Cholesteryl Ester Deposits on Monthly Replacement Silicone Hydrogel Contact Lens Materials
  31. Thirty years of ‘quiet eye’ with etafilcon A contact lenses
  32. The ocular surface, coronaviruses and COVID ‐19
  33. Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
  34. The Impact of Cosmetics on the Physical Dimension and Optical Performance of Contemporary Silicone Hydrogel Contact Lenses
  35. Kinetic Deposition of Polar and Non-polar Lipids on Silicone Hydrogel Contact Lenses
  36. The COVID-19 pandemic: Important considerations for contact lens practitioners
  37. Geographic distribution of corneal staining in symptomatic dry eye
  38. When was the last time you fitted a soft lens?
  39. Cytomorphological assessment of the lid margin in relation to symptoms, contact lens wear and lid wiper epitheliopathy
  40. The efficacy of povidone-iodine, hydrogen peroxide and a chemical multipurpose contact lens care system against Pseudomonas aeruginosa on various lens case surfaces
  41. Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update
  42. Adhesion of Pseudomonas aeruginosa, Achromobacter xylosoxidans, Delftia acidovorans, Stenotrophomonas maltophilia to contact lenses under the influence of an artificial tear solution
  43. Localization of full-length recombinant human proteoglycan-4 in commercial contact lenses using confocal microscopy
  44. The use of preservatives in dry eye drops
  45. The short-term physiological impact of switching reusable silicone hydrogel wearers into a hydrogel daily disposable multifocal
  46. An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction
  47. Hand hygiene is linked to microbial keratitis and corneal inflammatory events
  48. Novel in vitro method to determine pre-lens tear break-up time of hydrogel and silicone hydrogel contact lenses
  49. Efficacy of Contact Lens Care Solutions in Removing Cholesterol Deposits From Silicone Hydrogel Contact Lenses
  50. Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review
  51. The Case for Using Hydrogen Peroxide Contact Lens Care Solutions
  52. Uptake and Release of Polyvinyl Alcohol from Hydrogel Daily Disposable Contact Lenses
  53. IMI – Clinical Myopia Control Trials and Instrumentation Report
  54. IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report
  55. IMI – Myopia Control Reports Overview and Introduction
  56. IMI – Report on Experimental Models of Emmetropization and Myopia
  57. Impact of a Hyaluronic Acid-Grafted Layer on the Surface Properties of Model Silicone Hydrogel Contact Lenses
  58. Clinical factors associated with contact lens dropout
  59. Determination of the release of PEG and HPMC from nelfilcon A daily disposable contact lenses using a novel in vitro eye model
  60. A novel scale for describing corneal staining
  61. Depth Profile Assessment of the Early Phase Deposition of Lysozyme on Soft Contact Lens Materials Using a Novel In Vitro Eye Model
  62. Comparison of meibomian gland dropout using two infrared imaging devices
  63. Short-Term Comfort Responses Associated With the Use of Eyelid Cleansing Products to Manage Demodex folliculorum
  64. The Impact of Scleral Contact Lens Vault on Visual Acuity and Comfort
  65. Analysis of polyvinyl alcohol release from commercially available daily disposable contact lenses using an in vitro eye model
  66. Spectacle prescriptions review to determine prevalence of ametropia and coverage of frequent replacement soft toric contact lenses
  67. Functional Two- and Three-Dimensional Architectures of Immobilized Metal Nanoparticles
  68. Surface versus bulk activity of lysozyme deposited on hydrogel contact lens materials in vitro
  69. Cytotoxic and inflammatory effects of contact lens solutions on human corneal epithelial cells in vitro
  70. Tear evaporation rates: What does the literature tell us?
  71. The Effect of Denatured Lysozyme on Human Corneal Epithelial Cells
  72. Differential Deposition of Fluorescently Tagged Cholesterol on Commercial Contact Lenses Using a Novel In Vitro Eye Model
  73. Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
  74. A Rapid Extraction Method to Quantify Drug Uptake in Contact Lenses
  75. Myopia prevalence in Canadian school children: a pilot study
  76. A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day
  77. In Vitro Effect of Lysozyme on Albumin Deposition to Hydrogel Contact Lens Materials
  78. TFOS DEWS II Report Executive Summary
  79. In vitro release of two anti-muscarinic drugs from soft contact lenses
  80. A Review of Techniques to Measure Protein Sorption to Soft Contact Lenses
  81. Effect of Time on Scleral Lens Settling and Change in Corneal Clearance
  82. Lipid Deposition on Contact Lenses when Using Contemporary Care Solutions
  83. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome
  84. Consensus report: how to diagnose dry eye
  85. TFOS DEWS II Epidemiology Report
  86. TFOS DEWS II Introduction
  87. TFOS DEWS II Management and Therapy Report
  88. TFOS DEWS II Tear Film Report
  89. Selectivity and localization of lysozyme uptake in contemporary hydrogel contact lens materials
  90. Self versus examiner administration of the Ocular Surface Disease Index©
  91. The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals
  92. A Comparison of Dry Eye Diagnostic Tests Between Symptomatic and Asymptomatic Age-Matched Females
  93. A sixteen year survey of Canadian contact lens prescribing
  94. Release of Moxifloxacin from Contact Lenses Using an In Vitro Eye Model: Impact of Artificial Tear Fluid Composition and Mechanical Rubbing
  95. Pilot Study to Determine the Effect of Lens and Eye Rinsing on Solution-Induced Corneal Staining (SICS)
  96. Towards point-of-care detection of polymicrobial infections: Rapid colorimetric response using a portable spectrophotometer
  97. Effects of Antifungal Soaked Silicone Hydrogel Contact Lenses on Candida albicans in an Agar Eye Model
  98. Interactions between bacterial surface and nanoparticles govern the performance of “chemical nose” biosensors
  99. Impression Cytology of the Lid Wiper Area
  100. Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage
  101. Contact Lens Comfort
  102. Effect of Short Recovery Periods on Ocular Comfort During Daily Lens Wear
  103. Eyelid Margin and Meibomian Gland Characteristics and Symptoms in Lens Wearers
  104. Impact of Lens Care Solutions on Protein Deposition on Soft Contact Lenses
  105. Lid Wiper Epitheliopathy in Soft Contact Lens Wearers
  106. Microbial Contamination of Contact Lens Storage Cases During Daily Wear Use
  107. Subjective Comfort and Physiology with Modern Contact Lens Care Products
  108. Impact of Eye Cosmetics on the Eye, Adnexa, and Ocular Surface
  109. Corneal Swelling with Cosmetic etafilcon A Lenses versus No Lens Wear
  110. Development of an In Vitro Ocular Platform to Test Contact Lenses
  111. Assessment of biofilm formation of E. meningoseptica, D. acidovorans, and S. maltophilia in lens cases and their growth on recovery media
  112. Expert Views on Innovative Future Uses for Contact Lenses
  113. Global trends in myopia management attitudes and strategies in clinical practice
  114. Release of Fluconazole from Contact Lenses Using a Novel In Vitro Eye Model
  115. Revolutionary Future Uses of Contact Lenses
  116. The Use of Contact Lenses as Biosensors
  117. Variations in observable lid wiper epitheliopathy (LWE) staining patterns in wearers of silicone hydrogel lenses
  118. Colorimetric biosensing of pathogens using gold nanoparticles
  119. In Vitro Cholesterol Deposition on Daily Disposable Contact Lens Materials
  120. A Comparative Study Between an Oil-in-Water Emulsion and Nonlipid Eye Drops Used for Rewetting Contact Lenses
  121. Associations with Meibomian Gland Atrophy in Daily Contact Lens Wearers
  122. Controlling “chemical nose” biosensor characteristics by modulating gold nanoparticle shape and concentration
  123. Effect of Lid Debridement-Scaling in Sjögren Syndrome Dry Eye
  124. In vitro friction testing of contact lenses and human ocular tissues: Effect of proteoglycan 4 (PRG4)
  125. Biological and Clinical Implications of Lysozyme Deposition on Soft Contact Lenses
  126. Atomic force microscopy and Langmuir–Blodgett monolayer technique to assess contact lens deposits and human meibum extracts
  127. Competitive Effects from an Artificial Tear Solution to Protein Adsorption
  128. Impact of Cosmetics on the Physical Dimension and Optical Performance of Silicone Hydrogel Contact Lenses
  129. Impact of Cosmetics on the Surface Properties of Silicone Hydrogel Contact Lenses
  130. Analysis of Using I125Radiolabeling for Quantifying Protein on Contact Lenses
  131. Timolol maleate release from hyaluronic acid-containing model silicone hydrogel contact lens materials
  132. Release of Ciprofloxacin and Moxifloxacin From Daily Disposable Contact Lenses From an In Vitro Eye Model
  133. Efficacy of Antimicrobials against Biofilms of Achromobacter and Pseudomonas
  134. Clinical Performance of Three Silicone Hydrogel Daily Disposable Lenses
  135. Infrared Imaging of Meibomian Glands and Evaluation of the Lipid Layer in Sjogren's Syndrome Patients and Nondry Eye Controls
  136. Tear exchange and contact lenses: A review
  137. “Chemical nose” for the visual identification of emerging ocular pathogens using gold nanostars
  138. Kinetics of Competitive Adsorption between Lysozyme and Lactoferrin on Silicone Hydrogel Contact Lenses and the Effect on Lysozyme Activity
  139. In vitrodrug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials
  140. Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome
  141. Extended Latanoprost Release from Commercial Contact Lenses: In Vitro Studies Using Corneal Models
  142. Comparative Study of Lens Solutions’ Ability to Remove Tear Constituents
  143. Extraction versus In Situ Techniques for Measuring Surface-Adsorbed Lysozyme
  144. In Vitro and In Vivo Evaluation of Novel Ciprofloxacin-Releasing Silicone Hydrogel Contact Lenses
  145. Repeatability of Grading Meibomian Gland Dropout Using Two Infrared Systems
  146. Identification of coagulase-negative staphylococci in daily disposable contact lens wearers
  147. Contact lenses for antifungal ocular drug delivery: a review
  148. Branching and size of CTAB-coated gold nanostars control the colorimetric detection of bacteria
  149. Silicone Allergies and the Eye
  150. Quantification of Conjunctival TNF-α in Aqueous-Deficient Dry Eye
  151. A multi-country assessment of compliance with daily disposable contact lens wear
  152. Human Corneal Epithelial Cell Shedding and Fluorescein Staining in Response to Silicone Hydrogel Lenses and Contact Lens Disinfecting Solutions
  153. The TFOS International Workshop on Contact Lens Discomfort: Executive Summary
  154. The TFOS International Workshop on Contact Lens Discomfort: Introduction
  155. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Interactions With the Ocular Surface and Adnexa Subcommittee
  156. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Materials, Design, and Care Subcommittee
  157. Factors that Influence In Vitro Cholesterol Deposition on Contact Lenses
  158. In vitrouptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials
  159. Comfort Response of Three Silicone Hydrogel Daily Disposable Contact Lenses
  160. Re: Putting vital stains in context
  161. Exploring Compliance
  162. Imaging meibomian glands on a patient with chalazia in the upper and lower lids: A case report
  163. Contemporary dry eye tests
  164. Impact of Silicone Hydrogel Lenses and Solutions on Corneal Epithelial Permeability
  165. Inhibition of Defocus-Induced Myopia in Chickens
  166. Impact of tear film components on the conformational state of lysozyme deposited on contact lenses
  167. Compliance with Lens Replacement and the Interval between Eye Examinations
  168. In Vitro Uptake and Release of Natamycin From Conventional and Silicone Hydrogel Contact Lens Materials
  169. Physical Entrapment of Hyaluronic Acid During Synthesis Results in Extended Release From Model Hydrogel and Silicone Hydrogel Contact Lens Materials
  170. Impact of Time Between Collection and Collection Method on Human Tear Fluid Osmolarity
  171. Optimization of a Fluorescence-based Lysozyme Activity Assay for Contact Lens Studies
  172. 2. Contact lens care and ocular surface homeostasis
  173. 3. Ocular surface health with contact lens wear
  174. Historical overview of imaging the meibomian glands
  175. The Impact of Contemporary Contact Lenses on Contact Lens Discontinuation
  176. Uptake and Release Phenomena in Contact Lens Care by Silicone Hydrogel Lenses
  177. Wettability and Silicone Hydrogel Lenses
  178. Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(D,L-lactide)-b-Dextran Nanoparticles
  179. The Impact of Intermittent Air Exposure on Lipid Deposition
  180. Measuring the Modulus of Silicone Hydrogel Contact Lenses
  181. Protein Deposition and Clinical Symptoms in Daily Wear of Etafilcon Lenses
  182. Measuring the kinetics and activity of adsorbed proteins:In vitrolysozyme deposited onto hydrogel contact lenses over short time periods
  183. Delivery of Ketotifen Fumarate by Commercial Contact Lens Materials
  184. Molecular Structure of Interfacial Human Meibum Films
  185. The Impact of Tear Film Components on In Vitro Lipid Uptake
  186. Using anIn VitroModel of Lipid Deposition to Assess the Efficiency of Hydrogen Peroxide Solutions to Remove Lipid from Various Contact Lens Materials
  187. Photocrosslinkable hyaluronic acid as an internal wetting agent in model conventional and silicone hydrogel contact lenses
  188. The effects of hyaluronic acid incorporated as a wetting agent on lysozyme denaturation in model contact lens materials
  189. Infrared Imaging of Meibomian Gland Structure Using a Novel Keratograph
  190. Nanomaterials for Ocular Drug Delivery
  191. Impact of Tear Film Components on Lysozyme Deposition to Contact Lenses
  192. Protein deposition on contact lenses: The past, the present, and the future
  193. Correction
  194. Use of a Photographic Manipulation Tool to Assess Corneal Vascular Response
  195. Acetic and Acrylic Acid Molecular Imprinted Model Silicone Hydrogel Materials for Ciprofloxacin-HCl Delivery
  196. The Competing Effects of Hyaluronic and Methacrylic Acid in Model Contact Lenses
  197. Utilization of in vitro methods to determine the biocompatibility of intraocular lens materials
  198. Ability of patients to recall habitual contact lens products and enhancement of recall using photographic aids
  199. Quantification of Non-Polar Lipid Deposits on Senofilcon A Contact Lenses
  200. The University of Waterloo's Centre for Contact Lens Research
  201. The relationship between compliance with lens replacement and contact lens-related problems in silicone hydrogel wearers
  202. Influence of Protein Deposition on Bacterial Adhesion to Contact Lenses
  203. Hyaluronic acid as an internal wetting agent in model DMAA/TRIS contact lenses
  204. Outcomes of wavefront-guided laser in situ keratomileusis for hyperopia
  205. Impact of Multipurpose Solutions Released from Contact Lenses on Corneal Cells
  206. In Vitro Analysis of the Physical Properties of Contact Lens Blister Pack Solutions
  207. Patient Use of Smartphones to Communicate Subjective Data in Clinical Trials
  208. Effects of Silicone Hydrogel Contact Lens Wear on Ocular Surface Sensitivity to Tactile, Pneumatic Mechanical, and Chemical Stimulation
  209. Impact of a Rub and Rinse on Solution-Induced Corneal Staining
  210. Repeatability of Pachymetry and Thinnest Point Localization Using a Fourier-Domain Optical Coherence Tomographer
  211. Clinical performance of different care systems with silicone hydrogel contact lenses
  212. Innovation in contact lenses: basic research and clinical science
  213. Impact of fluorescent probes on albumin sorption profiles to ophthalmic biomaterials
  214. Influence of the Blink Interval on Tear Meniscus Height in Soft Contact Lens and Nonlens Wearers
  215. Tear lipocalin and lysozyme concentrations in postmenopausal women
  216. Comfort and Vision with Silicone Hydrogel Lenses: Effect of Compliance
  217. The Impact of Contact Angle on the Biocompatibility of Biomaterials
  218. Contact Lens Cases: The Missing Link in Contact Lens Safety?
  219. Compliance with Contact Lens Replacement in Canada and the United States
  220. Confocal microscopy and optical coherence tomography imaging of hereditary granular dystrophy
  221. Ex Vivo Protein Deposition on Bi-Weekly Silicone Hydrogel Contact Lenses
  222. In Vitro Contact Angle Analysis and Physical Properties of Blister Pack Solutions of Daily Disposable Contact Lenses
  223. Kinetics of Lysozyme Activity Recovered from Conventional and Silicone Hydrogel Contact Lens Materials
  224. Determination of albumin sorption to intraocular lenses by radiolabeling and confocal laser scanning microscopy
  225. Ex Vivo Protein Deposition on Bi-Weekly Silicone Hydrogel Contact Lenses
  226. Impact of Protein and Lipid on Neutralization Times of Hydrogen Peroxide Care Regimens
  227. Tear Meniscus Height Determination Using the OCT2 and the RTVue-100
  228. Uptake and Release of Dexamethasone Phosphate From Silicone Hydrogel and Group I, II, and IV Hydrogel Contact Lenses
  229. Patient and Practitioner Compliance With Silicone Hydrogel and Daily Disposable Lens Replacement in the United States
  230. Wavefront-guided LASIK for Myopia: Effect on Visual Acuity, Contrast Sensitivity, and Higher Order Aberrations
  231. Contact lens induced papillary conjunctivitis with silicone hydrogel lenses
  232. Efficacy of an Extraction Solvent Used to Quantify Albumin Deposition on Hydrogel Contact Lens Materials
  233. Protein Deposition on a Lathe-Cut Silicone Hydrogel Contact Lens Material
  234. Kinetics of in Vitro Lactoferrin Deposition on Silicone Hydrogel and FDA Group II and Group IV Hydrogel Contact Lens Materials
  235. Localization of Lysozyme Sorption to Conventional and Silicone Hydrogel Contact Lenses Using Confocal Microscopy
  236. Imaging Protein Deposits on Contact Lens Materials
  237. Thickness Mapping of the Cornea and Epithelium Using Optical Coherence Tomography
  238. Conjunctival and Corneal Hyperesthesia in Subjects with Dryness Symptoms
  239. Quartz crystal microbalance study of protein adsorption kinetics on poly(2-hydroxyethyl methacrylate)
  240. Albumin adsorption to contact lens materials: A review
  241. Dry Eye Symptoms Assessed by Four Questionnaires
  242. Epithelial Thickness Changes from the Induction of Myopia with CRTH RGP Contact Lenses
  243. Subjective and Objective Variation of the Tear Film Pre- and Post-Sleep
  244. Tear Lipocalin and Lysozyme in Sj??gren and Non-Sjogren Dry Eye
  245. Size-dependent denaturing kinetics of bovine serum albumin adsorbed onto gold nanospheres
  246. Clinical signs and symptoms in post-menopausal females with symptoms of dry eye
  247. Comfort and Adaptation to Silicone Hydrogel Lenses for Daily Wear
  248. Conjunctival and Corneal Pneumatic Sensitivity Is Associated with Signs and Symptoms of Ocular Dryness
  249. Hyaluronic acid containing hydrogels for the reduction of protein adsorption
  250. Atypical manifestation of upper lid margin staining in silicone hydrogel lens wearers with symptoms of dry eye
  251. Physical Properties of Soft Contact Lens Solutions
  252. A Solid-Phase Assay for the Quantitation of Total Protein Eluted from Balafilcon, Lotrafilcon, and Etafilcon Contact Lenses
  253. Conformational and Quantitative Characterization of Lysozyme Extracted from Galyfilcon and Senofilcon Silicone Hydrogel Contact Lenses
  254. Immobilized hyaluronic acid containing model silicone hydrogels reduce protein adsorption
  255. Microbial Keratitis and the Role of Rub and Rinsing
  256. The Impact of Lipid on Contact Angle Wettability
  257. Apparent time-dependent differences in inferior tear meniscus height in human subjects with mild dry eye symptoms
  258. Confocal Microscopy and Albumin Penetration into Contact Lenses
  259. Variability of the Analysis of the Tear Meniscus Height by Optical Coherence Tomography
  260. Extraction Efficiency of an Extraction Buffer Used to Quantify Lysozyme Deposition on Conventional and Silicone Hydrogel Contact Lens Materials
  261. Growth Factors in the Tear Film: Role in Tissue Maintenance, Wound Healing, and Ocular Pathology
  262. Tear Osmolality and Ferning Patterns in Postmenopausal Women
  263. A Seven Year Survey of the Contact Lens Prescribing Habits of Canadian Optometrists
  264. Assessment of Variation in Bulbar Conjunctival Redness, Temperature, and Blood Flow
  265. Quantity and Conformation of Lysozyme Deposited on Conventional and Silicone Hydrogel Contact Lens Materials Using an In Vitro Model
  266. Contact Lenses in Suboptimal Environments
  267. Corneal Refractive Therapy with Different Lens Materials, Part 1: Corneal, Stromal, and Epithelial Thickness Changes
  268. Lipid Deposition on Hydrogel Contact Lenses: How History Can Help Us Today
  269. In Vitro Assessment of Medical Device Toxicity: Interactions of Benzalkonium Chloride With Silicone-Containing and p-HEMA???Containing Hydrogel Contact Lens Materials
  270. Objective and Subjective Responses in Patients Refitted to Daily-Wear Silicone Hydrogel Contact Lenses
  271. Anomalous thermal denaturing of proteins adsorbed to nanoparticles
  272. Rewetting Drops Containing Surface Active Agents Improve the Clinical Performance of Silicone Hydrogel Contact Lenses
  273. Validity of Pachymetric Measurements by Manipulating the Acoustic Factor of Orbscan II
  274. Kinetics ofIn VitroLysozyme Deposition on Silicone Hydrogel, PMMA, and FDA Groups I, II, and IV Contact Lens Materials
  275. Soft Lens Extended Wear and Complications
  276. Subconjunctival cyst-like formations following impression cytology
  277. Stabilization of Lysozyme Mass Extracted From Lotrafilcon Silicone Hydrogel Contact Lenses
  278. Corneal and Epithelial Thickness Changes After 4 Weeks of Overnight Corneal Refractive Therapy Lens Wear, Measured With Optical Coherence Tomography
  279. Drying methods for XPS analysis of PureVision™, Focus® Night&Day™ and conventional hydrogel contact lenses
  280. Corrigendum to “Tear turnover rate is reduced in patients with symptomatic dry eye” [Contact Lens Anterior Eye 27 (2004) 15–20]
  281. Tear turnover rate is reduced in patients with symptomatic dry eye
  282. Quantitative and conformational characterization of lysozyme deposited on balafilcon and etafilcon contact lens materials
  283. Survey of Bandage Lens Use in North America, October???December 2002
  284. Topographical Thickness of the Epithelium and Total Cornea after Overnight Wear of Reverse-Geometry Rigid Contact Lenses for Myopia Reduction
  285. Precorneal and Pre- and Postlens Tear Film Thickness Measured Indirectly with Optical Coherence Tomography
  286. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials
  287. Ciprofloxacin Interaction with Silicon-Based and Conventional Hydrogel Contact Lenses
  288. Asymptomatic Corneal Staining Associated with the Use of Balafilcon Silicone-Hydrogel Contact Lenses Disinfected with a Polyaminopropyl Biguanide-Preserved Care Regimen
  289. In vitro evaluation of the dehydration characteristics of silicone hydrogel and conventional hydrogel contact lens materials
  290. Relation between optical coherence tomography and optical pachymetry measurements of corneal swelling induced by hypoxia
  291. The application of counter immunoelectrophoresis (CIE) in ocular protein studies
  292. The measurement of corneal epithelial thickness in response to hypoxia using optical coherence tomography11Proprietary interests: The authors have no proprietary interest in any materials or methods described within this article.
  293. Non-inflammatory corneal complications of contact lens wear
  294. The ex vivo wettability of soft contact lenses
  295. An in Vivo Comparison of the Kinetics of Protein and Lipid Deposition on Group II and Group IV Frequent-Replacement Contact Lenses
  296. Epithelial Inclusions in Association with Mucin Ball Development in High-Oxygen Permeability Hydrogel Lenses
  297. Use of reverse geometry rigid gas permeable contact lenses in the management of the postradial keratotomy patient: review and case report
  298. Clinical comparison of three polyhexanide-preserved multi-purpose contact lens solutions
  299. Spoliation and Clinical Performance of Monthly vs. Three Monthly Group II Disposable Contact Lenses
  300. Disposable contact lenses: a review
  301. Effect of hydrogen peroxide neutralisation onthe fitting characteristics of group IV disposable contact lenses
  302. Pseudomonas corneal ulcers associated with daily wear of disposable hydrogel contact lenses
  303. Corneal ulcers associated with daily wear of disposable hydrogel contact lenses
  304. Possible allergic reactions to cyclopentolate hydrochloride: case reports with literature review of uses and adverse reactions
  305. Bitoric hard and soft lenses in marked ocularastigmatism